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Synopsis
Metabolism and immune responses have been shown to be closely linked and as our understanding increases, so do
the intricacies of the level of linkage. NAD+ has previously been shown to regulate tumour necrosis factor-α (TNF-α)
synthesis and TNF-α has been shown to regulate NAD+ homoeostasis providing a link between a pro-inflammatory
response and redox status. In the present study, we have used THP-1 differentiation into pro- (M1-like) and anti- (M2-
like) inflammatory macrophage subset models to investigate this link further. Pro- and anti-inflammatory macrophages
showed different resting NAD+ levels and expression levels of NAD+ homoeostasis enzymes. Challenge with bacterial
lipopolysaccharide, a pro-inflammatory stimulus for macrophages, caused a large, biphasic and transient increase
in NAD+ levels in pro- but not anti-inflammatory macrophages that were correlated with TNF-α release and inhibition
of certain NAD+ synthesis pathways blocked TNF-α release. Lipopolysaccharide stimulation also caused changes in
mRNA levels of some NAD+ homoeostasis enzymes in M1-like cells. Surprisingly, despite M2-like cells not releasing
TNF-α or changing NAD+ levels in response to lipopolysaccharide, they showed similar mRNA changes compared
with M1-like cells. These data further strengthen the link between pro-inflammatory responses in macrophages and
NAD+ . The agonist-induced rise in NAD+ shows striking parallels to well-known second messengers and raises the
possibility that NAD+ is acting in a similar manner in this model.
Key words: immune responses, lipopolysaccharide (LPS), macrophages, pyridine nucleotides, second messenger,
TNF-α.
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INTRODUCTION
Previous work has revealed a fascinating link between metabol-
ism and the ability of an organism to mount an immune response
[1]. This link is bidirectional with examples of changes in meta-
bolism being required in order to mount the appropriate response
and with immune mediators being able to modulate metabolism
[2]. Indeed, many diseases that were previously considered to
be pure metabolic disorders now being reconsidered also as in-
flammatory diseases and vice versa [2]. Immunometabolism has
been particularly well studied in macrophages, myeloid derived
phagocytes with different phenotypes that can be involved in nu-
merous innate immune functions from bacterial killing to wound
healing [3]. In particular, classically activated, pro-inflammatory
(M1) macrophages are predominantly glycolytic whereas altern-
atively activated; anti-inflammatory (M2) macrophages rely on
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oxidative metabolism [4]. Forcing M1s to become oxidative, or
M2s to become glycolytic, leads to a switch in phenotype. A
front-line response to bacterial infection needs to be short lived as
the consequent production of large amounts of pro-inflammatory
mediators such as tumour necrosis factor-α (TNF-α) can lead to
a pro-inflammatory cascade resulting in potentially fatal cytokine
storm [5].
Glycolysis can operate under anaerobic conditions (such as
those that may be found at sites of infection) for short periods
of time but is unsustainable in the long term due to lactate and
ROS production, reflecting the role of M1s. On the other hand,
M2s are involved in much longer term anti-inflammatory pro-
cesses in which cytokine storm is not possible. Thus M2s are
much more suited to aerobic oxidative metabolism of glucose
and fatty acids which, while slower than glycolysis, produces
more ATP per gram of substrate and can be sustained practically
indefinitely. Given that NAD+ is an absolute requirement for
c© 2016 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0. 1
A.J. Al-Shabany and others
glycolysis, it is perhaps not surprising that NAD+ levels have
also been linked to immune function in macrophages. Indeed, a
key role has been shown for NAD+ in the positive control of
transcription of the major M1 pro-inflammatory cytokine TNF-α
via NAD+ -dependent sirtuin deacetylase activity [6]. Decreasing
NAD+ levels, SIRT6 knock out or inhibition, blocks transcription
of TNF-α suggesting a link between the redox and thus metabolic,
state of cell and pro-inflammatory responses. During glycolysis,
NAD+ is reduced to NADH whereas NADH can be oxidized
back to NAD+ during anaerobic lactic fermentation or during mi-
tochondrial oxidative phosphorylation [7], thus, NAD+ /NADH
ratios provide readout of glycolytic activity that would appear
to be important in the regulation of TNF-α transcription. Con-
versely, it has been found that TNF-α itself can modulate intracel-
lular NAD+ content in macrophages, by regulating the expres-
sion of a number of NAD+ homoeostasis enzymes, presumably
as some sort of feedback regulation [8]. Furthermore, LPS, a clas-
sic pro-inflammatory stimulus that leads to TNF-α release, has
also been shown to mediate the expression of NAMPT (nicotin-
amide phosphoribosyl transferase, a key enzyme in the NAD+ re-
cycling pathway) in activated monocytes and macrophages [8,9].
It is thus clear that NAD+ is involved in macrophage pro-
inflammatory responses involving TNF-α. Previous interest in
the pharmacological modulation of NAD+ homoeostasis has led
to a number of drugs entering clinical trials as chemotherapeutic
agents for cancer [10]. Given the link between NAD+ and TNF-
α, it is also possible that such agents could be used to mod-
ulate pro-inflammatory responses. Indeed, FK866, an inhibitor
of the NAD+ recycling pathway, decreased TNF-α secretion in
THP-1 monocytes and human monocyte during LPS stimulation
[10,11]. We have investigated whether NAD+ levels could also
be involved in the LPS-stimulated secretion of TNF-α in mono-
cytic THP-1 cells differentiated to generate M1-like and M2-like
macrophage models. The generated subsets differed in their rel-
ative levels of expression of NAD+ -homoeostasis enzymes and
in their resting levels of NAD+ suggesting that NAD+ homoeo-
stasis may be phenotype specific. LPS induced robust TNF-α
production that was accompanied by large changes in intracel-
lular NAD+ levels in M1-like cells, whereas this was not the
case in M2-like cells. LPS also induced changes in the expres-
sion of NAD+ -homoeostasis enzymes that differed between sub-
sets. These data extend the intimate relationship between NAD+
levels and homoeostasis and TNF-α. Furthermore, to our know-
ledge, this is the first report of agonist stimulated NAD+ rises
and bringing NAD+ a step closer to being classified as a second
messenger.
MATERIALS AND METHODS
Cell culture maintenance, macrophage
differentiation and stimulation
The human monocytic leukaemia cell line THP-1 (ECACC) was
used routinely between passage 8 and 24 and maintained in
complete growth RPMI 1640 medium (Lonza) supplemented
with 10 % (v/v) FBS (Sera lab), 2 mM L-glutamine, 100 unit/ml
penicillin and 100 μg/ml streptomycin (P/S) (Lonza). Cells were
kept at 37 ◦C, under 5 % CO2 in a humidified incubator.
For THP-1 differentiation into macrophage-like subsets, the
cells were plated (at density of 1 × 106 cell/ml) in complete me-
dium and treated with PMA (M1-like; 25 ng/ml; 3 days followed
by 5 days resting in fresh medium) or 1,25-(OH)2-Vitamin D3
(Sigma–Aldrich; M2-like; 10 nM; 7 days) [12].
Cells were stimulated with 100 ng/ml LPS derived from Es-
cherichia coli K12-LPS (Autogen-Bioclear Ltd.) for the indic-
ated time intervals. Dead cells were aspirated and the live cells
and supernatant were harvested by centrifugation at 200 g for
5 min, and stored at − 20 ◦C until the day of analysis. For cell
counting, adherent cells (M1-like) were de-attached by trypsin-
ization using 0.5 % (v/v) of trypsin with 0.2 % (v/v) EDTA
(Sigma–Aldrich).
NAD+ cycling assay for the measurement of
intracellular NAD+ levels
For the determination of NAD+ content, the washed cell pel-
lets were lysed with 0.2 M HCl and heated to 100 ◦C for
10 min. The intracellular NAD+ content were measured us-
ing a modified enzymatic cycling assay [13]. Briefly, the acid
extract was mixed with 151 μl of cycling buffer: 98 mM bi-
cine pH 8.0, containing 0.2 M sodium hydroxide, 1.63 mM
PES (phenazine ethosulfate), 0.412 mM MTT (3-(4,5-Dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide), 9.8 % (v/v)
absolute ethanol, 3.92 mM EDTA and 5 μl of yeast alco-
hol dehydrogenase (ADH) (400 unit/mg) were incubated for
30 min in the dark at room temperature. The absorbance was
read at 565 nm using a plate reader (Versa Max, Molecular
Devices).
Quantitative analysis of cytokine levels
To quantify extracellular TNF-α levels, cell culture supernatants
were analysed using sandwich ELISA according to the manufac-
turer’s instructions. Supernatants were harvested from THP-1-
derived macrophage subsets at the indicated time points, and pro-
tocols were followed and compared with standard curves between
the range of 7 and 5000 pg/ml using the international standards
available from NIBSC, Potter’s Bar, UK. Briefly, 96-well ELISA
plates (Nunc, Fisher Scientific) were coated with (4 μg/ml) of
mouse anti-human TNF-α (BD Pharmingen), in PBS as a coat-
ing buffer, and incubated overnight at 4 ◦C.
Thereafter, samples were added into the plate, and incubated
overnight at 4 ◦C. For TNF-α detection, biotinylated mouse anti-
TNF-α at 1 μg/ml in 2 % BSA (w/v in PBS) buffer were applied,
and horseradish peroxidase streptavidin conjugate were added,
followed by incubation with TMB reagent (Insight Biotechno-
logy Ltd.). Colorimetric development was assayed spectropho-
tometrically by an OPTI Max tuneable microplate reader set to
450 nm and analysed by Soft max Pro version 2.4.1 software
(Versa Max, Molecular Devices).
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Table 1 Primer sequences used for qPCR
Gene Sequence (5′ ➔ 3′) Size (bp) Gene Sequence (5′ ➔ 3′) Size
GAPDH For: CCCACTCCTCCACCTTTGAC 20 IDO For: GCCTGCGGGAAGCTTATG 18
Rev: CTGTTGCTGTAGCCAAATTCGT 22 Rev: TGGCTTGCAGGAATCAGGAT 20
CD38 For: GCACCACCAAGCGCTTTC 18 NMNAT For: TCATTCAATCCCATCACCAACA 22
Rev: TCCCATACACTTTGGCAGTCTACA 24 Rev: AGGAGAGATGATGCCTTTGACAA 23
CD157 For: GGGAAGGCAGCATGAAAGTC 20 NAMPT For: TCCGGCCCGAGATGAAT 17
Rev: GGTCCACGCACTGTAAGAGCTT 22 Rev: TGCTTGTGTTGGGTGGATATTG 22
RNA extraction, reverse transcription and qPCR
Total RNA was extracted from approximately 1 × 106 cultured
cells, and isolated using Gen Elute Mammalian Total RNA kit
(Sigma–Aldrich) with a DNase I Digestion treatment for 15 min
according the manufacturer’s instructions. The amount and purity
of RNA was measured using a Nano-drop Plus spectrophotometer
(Bioscience, Cambridge Bioscience Ltd). Total RNA (25 ng/ml)
was subsequently reverse transcribed in 20 μl total volume con-
taining: 2.5 μM random nonamers, 10 unit/μl RT and 500 μM
deoxynucleotide mixture, for 1 h at 42 ◦C before quantitative PCR
(qPCR) was performed. The primers used for qPCR are listed in
Table 1.
The qPCR was performed to quantify specific mRNA using
SYBR green detection kit according to the manufacturer’s in-
structions (Sigma–Aldrich). The cDNA product was utilized in
the reaction mixture with 0.4 μM of specific forward/reverse
primer sets alongside with (0.025 unit/μl reaction) of SYBR-
Green Jumpstart Tag ready mixture (Sigma–Aldrich). The reac-
tions were performed under the following conditions: 94 ◦C for
2 min followed by 40 cycles of 94 ◦C for 30 s, 60 ◦C for 30 s and
72 ◦C for 30 s. The quality of the RNA samples was confirmed by
1.5 % (w/v) agarose gel electrophoresis. The relative amounts of
mRNA, for each target transcript, were normalized according to
the house-keeping gene (GAPDH) glyceraldehyde-3-phosphate
dehydrogenase [14].
Statistical analysis
Statistical calculations were performed using Statgraphics Cen-
turion XVI (Stat Point Technologies Inc.). All data were tested for
normality using the Anderson–Darling test (P < 0.05 was used as
the cut off for non-normal data). Levene’s test was used to check
for differences in variance between each group. For normally
distributed data, one-way ANOVA followed by Tukey’s test was
performed. Data are reported as means +− S.E.M. for triplicate
samples from three independent experiments unless otherwise
indicated. Differences were considered significant if P < 0.05.
RESULTS
The link between NAD+ and TNF-α is now well established
in macrophages. Briefly, NAD+ regulates production of TNF-α
in a sirtuin-dependent manner [6] and TNF-α has been shown
to modulate the expression of a number of enzymes that are in-
volved in NAD+ homoeostasis [8]. In order to investigate this
link further, intracellular NAD+ level changes have been invest-
igated during LPS stimulation of THP-1 monocytic cell line-
derived macrophages. This system has been shown to generate
cells that express markers and are functionally very close to pro-
(M1) or anti- (M2) inflammatory macrophages [12,15]. Due to
the heterogeneity of macrophage function, distinct M1-like pro-
inflammatory and M2-like anti-inflammatory phenotypes were
investigated to elucidate any potential differences. Upon LPS
stimulation, M1-like cells showed a distinctive change in NAD+
levels that consisted of an initial fast increase, peaking at 30 min
followed by a lower but sustained high level of NAD+ that lasted
for several hours, starting to return to unstimulated levels at 24 h
post-stimulation. Unstimulated cells showed a constant low level
of NAD+ throughout the experiment (Figure 1A). In contrast,
LPS stimulation of M2-like cells failed to increase intracellular
NAD+ levels and both stimulated and unstimulated cells showed
similar levels of NAD+ throughout the experiment. Basal levels
of NAD+ in unstimulated M1-like and M2-like cells were dif-
ferent with M1-like cells appearing to have three-fold higher
level of NAD+ than M2-like cells (Figures 1A and 1B). Dur-
ing stimulation experiments, media was collected and secreted
TNF-α assayed over the same time course. As expected, M1-like
cells showed significant TNF-α secretion that peaked at 8 h and
decayed back to basal levels by 24 h (Figure 1C). In contrast,
M2-like cells secreted a relatively small amount of TNF-α which
corresponded to less than 10 % of that secreted by M1-like cells
(Figure 1D). In M2-like cells, the TNF-α peak was short lived
and had returned almost to basal levels by 8 h however there was
a low level of TNF-α that persisted to beyond 18 h.
These results suggest that LPS affects NAD+ homoeostasis
differently in the two phenotypes. While conducting experiments
to assess the effect of the NAD+ -recycling (NAMPT) inhibitor
FK866 in the two phenotypes in the absence of LPS stimula-
tion, we noticed opposing effects on NAD+ levels. In M2-like
cells, FK866 reduced the levels of NAD+ over time as would be
expected due to inhibition of NAD+ synthesis and constitutive
NAD+ consumption (Figure 2B). In M1-like cells, on the other
hand, FK866 gradually increased NAD+ levels over time (Fig-
ure 2A). We are unsure as to how FK866 can cause an increase
in NAD+ levels but this does suggest that there is a funda-
mental difference in how the two phenotypes perform NAD+ ho-
moeostasis. To check whether the two phenotypes show different
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Figure 1 Intracellular NAD+ and TNF-α levels in THP-1-derived macrophages subsets
LPS effect on NAD+ levels in pro-inflammatory (A; M1-like) and anti-inflammatory (B; M2-like) macrophages. TNF-α levels
in M1-like (C) and M2-like (D) macrophages after LPS challenge. Data shown are mean+−S.E.M. for three separate
experiments (n = 3).
expression of some key regulators of NAD+ homoeostasis, real-
time qPCR (RT-qPCR) was performed on unstimulated M1-like
and M2-like cells and compared with expression in the monocytic
progenitor THP-1 cell line (Figure 3). Both phenotypes showed
increased expression of IDO compared with THP-1. The NADase
CD38, that mediates NAD+ degradation and generates cyclic
ADP ribose/NAADP [16], was significantly up-regulated in M1-
like and down-regulated in M2-like cells whereas the opposite
was true for CD157, a homologue of CD38 [17]. Finally, NM-
NAT (nicotinamide mononucleotide adenylyl transferase) that
catalyses the final step in NAD+ biosynthesis [18], was slightly,
but not significantly up-regulated in both phenotypes whereas
NAMPT was significantly up-regulated only in M1-like cells.
To further investigate this and the source of the LPS-induced
rise in NAD+ in M1-like cells, LPS stimulation of M1-like cells
was performed in the presence of diphenyliodonium (DPI), an
NAD(P)H oxidase (flavoenzyme) inhibitor, FK866 a NAMPT in-
hibitor or 1-MT, an IDO inhibitor. Concurrently TNF-α secretion
was measured. In M1s, DPI was able to significantly attenuate
both the initial NAD+ peak and the sustained rise caused by
LPS suggesting that one source of the NAD+ is the oxidation of
NADH during the respiratory burst as might be expected (Fig-
ure 4A). Surprisingly, both FK866 and 1-MT were also able to
attenuate both the initial peak and the sustained rise in NAD+
perhaps suggesting that multiple pathways lead to LPS-induced
NAD+ level rises (Figures 4B and 4C). Most striking was the
effect of the inhibitors on TNF-α production. DPI was able to
almost completely abolish TNF-α secretion although a small
amount was secreted over 8–24 h but significantly less than in
the absence of DPI (Figure 5A). FK866 was able to partially
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Figure 2 Effect of FK866 (100 nM) on NAD+ levels in M1-like (A) and M2-like (B) macrophages
Data shown are mean+−S.E.M. for three separate experiments (n = 3).
Figure 3 Gene expression profiles of NAD+ homoeostasis enzymes in M1- and M2-like macrophages relative to THP-1
monocytes
Data shown are mean+−S.E.M. of fold change for three separate experiments (n = 3–5). The data were analysed by
one-way ANOVA. *P<0.05.
attenuate TNF-α secretion whereas 1-MT had no effect (Fig-
ures 5B and 5C). These data suggest that the link between NAD+
and TNF-α secretion is perhaps complex and may require both
NAD+ and the activity of NAD(P)H oxidase.
Finally, it was assessed whether LPS stimulation and the con-
current changes in NAD+ levels and TNF-α secretion were able
to feedback and affect the expression of some key regulators of
NAD+ homoeostasis over 24 h. In M1-like cells, LPS stimu-
lation caused a significant increase in IDO mRNA with smal-
ler increases in CD38, CD157 and NAMPT expression whereas
NMNAT expression was unaffected (Figure 6A). The increase
was only significant for CD38. Despite LPS not being able to
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Figure 4 Pharmacological modulation of intracellular NAD+ levels by DPI (A), FK866 (B) and 1-MT (C) in M1-like cells
Data shown are mean+−S.E.M. for three separate experiments (n = 3–4).
stimulate NAD+ changes in M2-like cells, LPS stimulation
caused a similar but significant increase in IDO and in NAMPT
expression (Figure 6B). CD38, CD157 and NMNAT expression
were largely unaffected although there was a modest but signi-
ficant increase in NMNAT and CD38 expression.
DISCUSSION
It is becoming clear that cellular metabolic status is intrinsically
linked to immune system function, particularly in macrophages
[4]. One of the best studied links is that between NAD+ /NADH
and TNF-α with NAD(H) levels known to regulate TNF-α syn-
thesis [6] and TNF-α levels known to regulate expression of
NAD(H) homoeostasis enzymes [8]. In the present study, we
have further extended the knowledge on this link by showing
that TNF-α release is also correlated to NAD+ levels in a pro-
inflammatory (M1-like) macrophage model. Our data show that
LPS stimulation of M1-like cells induces a biphasic rise in NAD+
levels. LPS is well known to activate NAD(P)H oxidase [19], in a
Toll-like receptor 4 (TLR4)-dependent manner (oxidative burst)
which catalyses the oxidation of NAD(P)H to NAD+ [20]. This
may explain, at least in part, the rapid peak that was observed
in NAD+ levels as this was partially inhibited by the NAD(P)H
oxidase inhibitor DPI. However, both FK866 (an NAD+ recyc-
ling inhibitor) and 1-MT (an IDO inhibitor) were also able to
partially inhibit this initial rise. This may suggest that the NAD+
is also derived from a number of different synthesis and recyc-
ling pathways. The sustained rise in NAD+ levels also suggests
that NAD+ synthesis occurs as it would be expected that the
cell would return the redox balance after the oxidative burst rel-
atively rapidly so as to maintain the NAD+ /NADH ratio. Thus,
it would appear that LPS has a direct effect on NAD+ levels in
M1-like cells. LPS was unable to alter NAD+ levels in M2-like
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Figure 5 Pharmacological modulation of TNF-α release by DPI (A), FK866 (B) and 1-MT (C) in M1-like cells
Data shown are mean+−S.E.M. for three separate experiments (n = 4).
cells. NAD+ levels also appear to be correlated with secretion
of TNF-α. In M1-like cells, LPS induced a robust secretion of
TNF-α which was almost completely blocked by DPI and par-
tially inhibited by FK866 suggesting that NAD+ levels are, in
some way, related to TNF-α secretion. The exact mechanism is
unclear but is has been shown that TNF-α secretion requires act-
ive glycolysis [21]. Glycolysis is inhibited by high NADH levels
as NAD+ is absolutely required as a coenzyme. Both oxidation
of NADH to NAD+ and a simple increase in NAD+ synthesis
could both provide these conditions. Indeed, lactic fermentation
exists to oxidize NADH to NAD+ under anaerobic conditions
such that glycolysis may continue. M2-like cells responded to
LPS by releasing a relatively small amount of TNF-α. Crucially,
this was not associated with any changes in NAD+ levels, sug-
gesting that the signalling between TLR4 and TNF-α release is
via a different pathway compared with M1-like cells. TLR4 is
known to signal via different intracellular pathways, one of which
is NAD(P)H oxidase dependent which causes the oxidative burst
and ROS production [22] and converts NADH to NAD+ [20].
One interesting outcome from our data is that the two different
phenotypes appear to have quite different mechanisms and levels
of machinery for NAD+ homoeostasis, raising the exciting pos-
sibility that NAD+ homoeostasis may be phenotype-specific and
even an underlying cause of phenotypic differences. Indeed, pre-
vious work has shown that NAD+ and TNF-α are inextricably
linked suggesting that high NAD+ may be ‘pro-inflammatory’
[6,8,23]. We found that resting NAD+ levels were higher in M1-
like than M2-like cells and this may be linked with the finding
that M1s are predominantly glycolytic [24] and thus, require re-
latively more NAD+ . M1-like cells, in resting state, displayed
higher expression of the recycling pathway enzymes NAMPT
than both M2-like cells and the parent THP-1 cells as well
as higher levels of the NADase CD38. The CD38 homologue
and NADase CD157, however, displayed higher expression in
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Figure 6 Gene expression profile of NAD+ homoeostasis enzymes in M1-like (A) and M2-like (B) macrophages after LPS
challenge
Gene expression is expressed as fold change relative to the control. Data shown are mean+−S.E.M. for three separate
experiments (n = 4). The data were analysed by one-way ANOVA. *P<0.05.
M2-like cells, the converse of CD38. NAMPT is the rate limiting
enzyme in the NAD+ recycling pathway [25], this pathway is the
most active of the three known pathways that lead to NAD+ syn-
thesis; the others being the de novo (IDO) pathway [26] and the
nicotinamide riboside kinase (NRK) pathway [27]. The greatest
increase in expression, compared with parent THP-1 cells, was
in IDO in both phenotypes and it might be expected that the de
novo pathway would, thus, be the biggest contributor to NAD+
levels. However, this pathway is known to contribute little to the
intracellular NAD+ pools with as little as 1 in 60 molecules of
NAD+ being derived from tryptophan [28]. As NAD+ levels
represent a steady state between synthesis and degradation, it is
perhaps surprising that the NADase, CD38, was also up-regulated
in M1-like cells. This may reflect greater turnover of NAD+ in
these cells or that the increase in CD38 is related to its receptor
functions. CD38 is unusual in that it can act as both a cell surface
receptor (binding to adhesion molecule-1, CD31) and as an en-
zyme [29] but our knowledge of how exactly the two functions
interact is scant [30]. CD38 is known to be a marker of classically
activated (M1-like) macrophages [31] and our results suggest that
CD38 might contribute to differentiated macrophage responses.
For the M2-like cells, aside from modest increases in IDO and
CD157 expression, NAD+ homoeostasis enzymes were largely
unchanged compared with the parent THP-1 cells.
Finally the gene expression of the same enzymes was in-
vestigated after LPS challenge. In M1-like cells, mRNA ex-
pression of all enzymes except NMNAT increased over 20 h
after LPS addition with the largest effects on IDO and CD38.
Iqbal and Zaidi [8] have shown that TNF-α application to mac-
rophages increased the expression of the same enzymes although
they also showed an increase in NMNAT expression. Further-
more, Fedele et al. [29] also showed that LPS increases CD38
expression in monocyte-derived dendritic cells in an NF-κB-
dependent manner. It is likely that the TNF-α released during the
experiment is partially responsible for the expression observed
and thus why the results largely follow the same trend. However,
the data presented here were generated after LPS stimulation and
early signalling events may have initiated expression pathways
that were then augmented or modulated by autocrine/paracrine
signals upon TNF-α secretion. M2-like cells, that secreted a lesser
amount of TNF-α, showed subtle differences in expression pro-
files of the enzymes. Whereas IDO and CD38 both increased,
CD157 remained unchanged. Most striking was the differential
regulation of NMNAT and NAMPT mRNA expression. NAMPT
expression increased whereas NMNAT expression remained un-
changed. Large increases in NAMPT in M1 would suggest that
the cells are priming themselves for NAD+ production as this is
the rate limiting enzyme of the recycling pathway. Although we
have been unable to measure long-term effects after LPS stimula-
tion due to limitations in the cell model, it is tempting to postulate
that changes in NAD+ homoeostasis caused by these changes in
gene expression, might contribute to changes in cell phenotype
post-infection.
These data serve to reinforce the link between NAD+ , TNF-α
and inflammatory responses. Recent focus has shifted to the links
between metabolism and innate immune responses and NAD+
is a key player both as readout of the metabolic status of a cell
and as a signalling molecule. Of particular interest is that the two
phenotypes appear to have different mechanisms for handling
NAD+ and this may reflect different needs in terms of NAD+ .
Furthermore, their basal and stimulated expression profiles of a
number of NAD+ homoeostasis enzymes also differ suggesting
that they can further model how NAD+ homoeostasis is carried
out depending on the circumstances of the cell. Although NAD+
is central to the links between metabolism and immunology,
there has been precious little work on NAD+ homoeostasis in
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this context and this may prove to be an interesting avenue to
pursue in different aspects of immune responses.
Finally, that LPS induces rises in NAD+ levels, suggests that
NAD+ may be acting in a similar manner to a classical second
messenger. Indeed, of the five criteria suggested by Sutherland
[32], we have shown NAD+ fulfilling four in this work namely:
agonist stimulated changes in NAD+ levels, NAD+ synthesis
and degradation, antagonism of NAD+ action blocking the cel-
lular response and intracellular NAD+ targets. This cell/response
system is not ideal for intracellular application of NAD+ as cell
damage may release TNF-α making any observations hard to
interpret but should intracellular NAD+ application be shown
to mimic agonist responses in another system, NAD+ could be
regarded as a true second messenger, albeit a slightly unusual
one.
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